Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CytoSorbents Expanding Marketing Reach Of CytoSorb Blood Purifier

This article was originally published in Clinica

Executive Summary

CytoSorbents is sponsoring the REFRESH I trial of its CytoSorb extracorporeal cytokine adsorber in the US, which the company hopes will support approval of a pivotal trial of the device for reducing reduce plasma free hemoglobin and cytokines in patients undergoing complex cardiac surgery.

Advertisement

Related Content

Clinical Corner: New Data From Xeltis Bioabsorbable Heart Repair Devices Headlines Trial News

Topics

Advertisement
UsernamePublicRestriction

Register